Stocks · Health care · Pharmaceutical Preparations

Ultragenyx Pharmaceutical Inc.

RARE Clue Score44
United States Fiscal year ends December CIK 0001515673 Results filed 3 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Thomas Richard Kassberg
23 Oct 2023
Cbo & EVP
Sold after exercise
39,878
$32.78
$1.31M
Emil D Kakkis
19 Oct 2023
President & CEO
Sold after exercise
47,853
$33.52
$1.60M
Theodore Alan Huizenga
7 Sep 2023
SVP, Chief Accounting Officer
Sold after exercise
163
$38.34
$6.25K
Theodore Alan Huizenga
7 Sep 2023
SVP, Chief Accounting Officer
Sold after exercise
2,000
$41.00
$82.00K
Karah Herdman Parschauer
8 Sep 2021
EVP and General Counsel
Sold after exercise
7,336
$100.65
$738.37K
Camille L Bedrosian
2 Sep 2021
EVP and Chief Medical Officer
Sold after exercise
2,500
$100.18
$250.45K
Camille L Bedrosian
1 Sep 2021
EVP and Chief Medical Officer
Sold after exercise
2,500
$100.03
$250.08K
Camille L Bedrosian
15 Apr 2021
EVP and Chief Medical Officer
Sold after exercise
5,000
$109.09
$545.45K
William Aliski
19 Feb 2021
Director
Sold after exercise
7,500
$149.01
$1.12M
Camille L Bedrosian
15 Jan 2021
EVP and Chief Medical Officer
Sold after exercise
25,000
$139.18
$3.48M
Theodore Alan Huizenga
7 Jan 2021
SVP, Controller and PAO
Sold after exercise
4,000
$140.65
$562.60K
Karah Herdman Parschauer
30 Oct 2020
EVP and General Counsel
Sold after exercise
9,903
$100.12
$991.49K
Karah Herdman Parschauer
28 Oct 2020
EVP and General Counsel
Sold after exercise
97
$100.00
$9.70K
Karah Herdman Parschauer
8 Oct 2020
EVP and General Counsel
Sold after exercise
10,000
$95.00
$950.00K
Karah Herdman Parschauer
6 Oct 2020
EVP and General Counsel
Sold after exercise
10,000
$90.00
$900.00K
Karah Herdman Parschauer
23 Sep 2020
EVP and General Counsel
Sold after exercise
10,000
$85.00
$850.00K
William Aliski
21 Aug 2020
Director
Sold after exercise
5,000
$86.57
$432.85K
Shalini Sharp
17 Aug 2020
CFO & Executive Vice President
Sold after exercise
3,669
$88.38
$324.27K
Shalini Sharp
17 Aug 2020
CFO & Executive Vice President
Sold after exercise
7,188
$88.38
$635.28K
Shalini Sharp
17 Aug 2020
CFO & Executive Vice President
Sold after exercise
500
$88.38
$44.19K
Shalini Sharp
17 Aug 2020
CFO & Executive Vice President
Sold after exercise
2,560
$88.54
$226.66K
Shalini Sharp
17 Aug 2020
CFO & Executive Vice President
Sold after exercise
461
$88.24
$40.68K
Karah Herdman Parschauer
17 Aug 2020
EVP and General Counsel
Sold after exercise
2,370
$88.39
$209.48K
Karah Herdman Parschauer
17 Aug 2020
EVP and General Counsel
Sold after exercise
10,000
$88.44
$884.40K
Clay B Siegall
10 Aug 2020
Director
Sold after exercise
1,596
$85.01
$135.68K
Clay B Siegall
10 Aug 2020
Director
Sold after exercise
9,750
$85.01
$828.85K
Clay B Siegall
7 Aug 2020
Director
Sold after exercise
23,404
$85.55
$2.00M
Theodore Alan Huizenga
8 Jul 2020
SVP, Controller and PAO
Sold after exercise
2,000
$91.00
$182.00K
Theodore Alan Huizenga
8 Jul 2020
SVP, Controller and PAO
Sold after exercise
638
$91.00
$58.06K
Matthew K Fust
6 Jul 2020
Director
Sold after exercise
6,181
$90.00
$556.29K
Theodore Alan Huizenga
1 Jul 2020
SVP, Controller and PAO
Sold after exercise
1,500
$81.00
$121.50K
Theodore Alan Huizenga
1 Jul 2020
SVP, Controller and PAO
Sold after exercise
1,111
$81.00
$89.99K
Matthew K Fust
1 Jul 2020
Director
Sold after exercise
5,000
$85.00
$425.00K
Shalini Sharp
4 Jun 2020
CFO & Executive Vice President
Sold after exercise
2,564
$74.01
$189.76K
Shalini Sharp
3 Jun 2020
CFO & Executive Vice President
Sold after exercise
10,234
$74.23
$759.67K
Shalini Sharp
19 May 2020
CFO & Executive Vice President
Sold after exercise
3,907
$73.32
$286.46K
Shalini Sharp
19 May 2020
CFO & Executive Vice President
Sold after exercise
3,221
$73.32
$236.16K
Shalini Sharp
18 May 2020
CFO & Executive Vice President
Sold after exercise
2,392
$73.29
$175.31K
Shalini Sharp
18 May 2020
CFO & Executive Vice President
Sold after exercise
19,593
$73.34
$1.44M
William Aliski
18 May 2020
Director
Sold after exercise
7,500
$74.65
$559.88K
Theodore Alan Huizenga
15 May 2020
SVP, Controller and PAO
Sold after exercise
1,500
$71.00
$106.50K
Theodore Alan Huizenga
15 May 2020
SVP, Controller and PAO
Sold after exercise
961
$71.00
$68.23K
Shalini Sharp
18 Mar 2019
CFO & Executive Vice President
Sold after exercise
14,800
$70.00
$1.04M
Shalini Sharp
25 Sep 2018
CFO & Executive Vice President
Sold after exercise
6,700
$90.07
$603.47K
Theodore Alan Huizenga
15 Jun 2018
VP, Controller and PAO
Sold after exercise
955
$83.70
$79.93K
Shalini Sharp
7 Jun 2018
CFO & Executive Vice President
Sold after exercise
6,700
$80.07
$536.46K
Shalini Sharp
30 May 2018
CFO & Executive Vice President
Sold after exercise
13,000
$70.17
$912.17K
Shalini Sharp
2 Mar 2017
CFO & Executive Vice President
Sold after exercise
12,000
$90.10
$1.08M
Shalini Sharp
27 Feb 2017
CFO & Executive Vice President
Sold after exercise
12,000
$80.14
$961.68K
William Aliski
5 Dec 2016
Director
Sold after exercise
2,000
$78.70
$157.40K
William Aliski
5 Dec 2016
Director
Sold after exercise
4,000
$77.94
$311.76K
Theodore Alan Huizenga
16 Nov 2016
Controller and PAO
Sold after exercise
2,000
$79.73
$159.46K
Shalini Sharp
9 Nov 2016
CFO & Executive Vice President
Sold after exercise
700
$74.34
$52.04K
Shalini Sharp
9 Nov 2016
CFO & Executive Vice President
Sold after exercise
2,600
$73.65
$191.49K
Shalini Sharp
9 Nov 2016
CFO & Executive Vice President
Sold after exercise
3,205
$72.81
$233.36K
Shalini Sharp
9 Nov 2016
CFO & Executive Vice President
Sold after exercise
3,895
$71.68
$279.19K
Shalini Sharp
9 Nov 2016
CFO & Executive Vice President
Sold after exercise
13,600
$70.06
$952.82K

What was left out

Form 4 filings counted 449
Amendments (4/A) skipped 11
Filings about a different issuer 3
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 28
Sales straight out of an exercise 57
Sales at will 149
Transactions with no price 0
Shares from compensation/vesting 3,103,818
Sales filed before the plan box existed 100
History held since 3 Feb 2014